Whole genome sequencing analysis and fiber fluorescence in situ hybridization, which can be performed in fresh/frozen samples, could be employed to define whether the HER2 amplicon is syntenic or distributed in multiple chromosomal locations in HER2 heterogeneous cancers. This evidence concerns the gene ERBB2 and cancer.